Page last updated: 2024-08-17

medroxyprogesterone acetate and Adenocarcinoma

medroxyprogesterone acetate has been researched along with Adenocarcinoma in 160 studies

Research

Studies (160)

Timeframe	Studies, this research(%)	All Research%
pre-1990	70 (43.75)	18.7374
1990's	53 (33.13)	18.2507
2000's	25 (15.63)	29.6817
2010's	11 (6.88)	24.3611
2020's	1 (0.63)	2.80

Authors

Authors	Studies
Bispo, D; Fabris, V; Gil, AM; Helguero, LA; Lamb, CA; Lanari, C	1
Cohen, M; Danilack, VA; DiSilvestro, P; Fiascone, S; Kalife, E; Kao, MJ; Lokich, E; Luis, C; Robison, K; Singh, K	1
Hamada, M; Hasegawa, K; Ito, K; Katoh, T; Kozawa, E; Shintani, D; Yano, M; Yasuda, M	1
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY	1
Ankarali, H; Caglar, M; Mesci-Haftaci, S; Yavuzcan, A	1
Behbakht, K; Guy, MS; Post, MD; Qamar, L; Sartorius, CA; Sheeder, J; Spillman, MA	1
Cândido, EB; Carneiro, MM; Carvalho-Macedo, AC; Lara, AC; Rocha, AL; Silva-Filho, AL; Vidigal, PV	1
Bae, HS; Jung, YW; Kim, DH; Kim, M; Kim, MK; Seong, SJ; Shim, JY; Yun, BS	1
Carballo, N; Chiva, L; García, JF; González-Cortijo, L; Gonzalez-Martín, A; Lapuente, F; Rojo, A	1
Cao, Q; Feng, W; Feng, Y; Hua, K; Lu, X; Zhou, X	1
Kanemura, M; Ohmichi, M; Sasaki, H; Sekijima, T; Terai, Y; Yamashita, Y; Yasuda, M	1
Han, AR; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Kwon, YS; Nam, JH	1
Ferracone, JD; Hoppe, BR; Jacobs, TM; Poehlmann, CE; Sorenmo, KU	1
Chen, Y; Lv, W; Mao, Y; Wan, X; Xie, X	1
Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L	1
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Lee, SH; Nam, JH; Park, JY; Seong, SJ	1
Barnes, MN; Berry, WD; Grizzle, WE; Huh, WK; Kirby, TO; Leath, CA; Partridge, EE; Straughn, JM	1
Amezcua, CA; Boostanfar, R; Felix, JC; Roy, S; Stanczyk, FZ; Tourgeman, DE	1
MADDEN, EP	1
ANDERSON, DG	1
Blok, LJ; Brinkmann, AO; Burger, CW; Chadha-Ajwani, S; de Ruiter, PE; Gielen, SC; Grootegoed, JA; Hanekamp, EE; Huikeshoven, FJ; Kühne, LC; Smid-Koopman, E	1
Archer, DF; Leslie, S; Mirkin, S; Navarro, FJ	1
Aksu, T; Ayhan, A; Bozdag, G; Yarali, H	1
Efeyan, A; Fabris, V; Lanari, C; Merani, S; Molinolo, AA	1
Iwasaka, T; Kojima, K; Matsumoto, Y; Nakao, Y; Nomiyama, M; Yamasaki, F	1
Itoh, J; Kajiwara, H; Matsui, N; Miyamoto, T; Murakami, M; Osamura, RY; Shinozuka, T; Yasuda, M	1
Li, H; Sun, H	1
Lian, Z; Mori, H; Niwa, K; Onogi, K; Tagami, K; Tamaya, T	1
Cerchietti, LC; Diament, MJ; Klein, SM; Navigante, A; Peluffo, GD; Ranuncolo, SM; Stillitani, I	1
Fujiwara, T; Horie, K; Kugu, K; Minaguchi, T; Nakagawa, S; Nei, T; Osuga, Y; Takazawa, Y; Taketani, Y; Yano, T; Yasugi, T; Yoshikawa, H	1
Archer, DF; Mirkin, S	1
Cox, GG; Jewell, WR; Krishnan, EC; Lee, KR; Mebust, WK; Weigel, JW	1
de la Pena, MM; Deligdisch, L; Deppe, G; Fleming, H; Gurpide, E; Holinka, CF; Namit, C	1
Billiet, G; Bonte, J; De Hertogh, R; Ide, P; Vlaemynck, G	1
Carlino, F; Fiorentini, L; Mariani, G; Minervini, R	1
Grönroos, M; Kauppila, A; Nieminen, U	1
Murphy, GP	1
Fukushima, S; Furuhata, A; Kondo, I; Satomi, Y; Takai, S	1
Boyd, NR; Moazzami, B; Van der Walt, JD	1
Donadio, C; Giovannini, M; Rendina, GM	1
Dreikorn, K; Drings, P; Horsch, R; Palmtag, H; Rössler, W; Terwey, B	1
Cappelletti, V; Cozzoli, C; Di Fronzo, G; Dormia, E; Fontanella, U; Giannoni, R; Giongo, A; Lasio, E; Maggioni, A; Mastroberardino, E; Minervini, S; Piva, L; Pizzocaro, G; Ronchi, E; Salvioni, R; Zanollo, A	1
Hocke, M; Röttger, P; Stertmann, WA	1
Canigiula, L; Riundi, R; Scanni, A; Vezzoni, MA	1
Allegra, JC; Carlson, JA; Day, TG; Wittliff, JL	1
Donadio, C; Fabri, M; Mazzoni, P; Nazzicone, P; Rendina, GM	1
Szarvas, Z; Zsolnai, B	1
Cappelletti, V; Di Fronzo, G; Dormia, E; Giannoni, R; Giongo, A; Lasio, E; Maffeis, V; Piva, L; Pizzocaro, G; Ronchi, E; Salvioni, R; Zanollo, A	1
Asselain, B; Bretaudeau, B; Giralt, E; Jouve, M; Magdelenat, H; Merle, S; Palangie, T; Pouillart, P; Zajdela, A	1
Fujioka, H; Kotake, T; Matsuda, M; Nakano, E; Osafune, M; Sato, B; Sonoda, T; Tada, Y; Takaha, M	1
Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM	1
Ninagawa, T; Ohta, M; Takeda, A; Tomoda, Y	1
Cleary, RE; Ehrlich, CE; Young, PC	1
Aabo, K; Dombernowsky, P; Haid, I; Pedersen, AG	1
Bellini, O; Casazza, AM; Di Marco, A; Formelli, F; Zaccheo, T	1
Kauppila, A; Vihko, R	1
Concolino, G; Di Silverio, F; Marocchi, A; Toscano, V	1
McGoldrick, IA	1
Isojima, S; Kawakita, M; Koyama, K; Nakata, Y; Ogasawara, T; Takemura, T; Tsuji, Y	1
Charreau, EH; Dran, G; Lanari, C; Luthy, IA; Molinolo, AA; Montecchia, F; Pasqualini, CD	1
Mizuuchi, H; Mori, Y; Okamura, N; Sato, K	1
Fujita, H; Ishizaki, T; Itoh, R; Okada, H; Yamamoto, T; Yasuda, J	1
Bergh, A; Damber, JE; Grankvist, K; Henriksson, R; Widmark, A	1
Charreau, EH; Elizalde, PV; Gravano, M; Guerra, FK; Lanari, C; Lippman, ME; Lupu, R	1
Asaumi, S; Iino, Y; Ishikawa, H; Iwanami, K; Kawashima, K; Kobayashi, J; Kubota, K; Matsumoto, H; Morishita, Y; Yokoe, T	1
Cookson, KM	1
Gong, Y; Murphy, LC; Murphy, LJ	2
Itoh, M; Itoh, N; Morishita, S; Murase, T; Niwa, K; Shimokawa, K; Tamaya, T; Tanaka, T; Yokoyama, Y	1
Charreau, EH; Dran, G; Kordon, EC; Lanari, C; Molinolo, AA; Pasqualini, CD; Pazos, P	1
Charreau, EH; Ciuffo, GM; Elizalde, PV; Guerra, FK; Saavedra, JM	1
Acworth, P; Bourne, H; Haylock, BJ; Murrell, DS	1
Satyaswaroop, PG	1
Heineman, MJ; Ubachs, JM	1
Deerberg, F; Horn, DW; Schneider, MR; Vollmer, G	1
Joosten, JW; Kloosterboer, HJ; Schoonen, WG	1
Delmore, JE; Horbelt, DV; Parmley, TH; Roberts, DK; Walker, N	1
Ray, RM; Thomas, DB	1
Fujimoto, J; Hori, M; Ichigo, S; Morishita, S; Tamaya, T	1
Bamberger, AM; Bamberger, CM; Gellersen, B; Schulte, HM	1
Aldaz, CM; Johnston, DA; LaBate, M; Liao, QY	1
Rob, L	1
Fujimoto, J; Hori, M; Ichigo, S; Tamaya, T	1
Lane, G; Martin-Hirsch, P; Salha, O; Sharma, V	1
Charreau, EH; Elizalde, P; Lanari, C; Molinolo, AA; Montecchia, F; Pazos, P	1
Lamb, C; Lanari, C; Molinolo, A; Montecchia, F; Pazos, P; Simian, M; Vanzulli, S	1
Lamb, C; Lanari, C; Molinolo, AA; Montecchia, MF; Pazos, P; Simian, M; Vanzulli, S	1
Balaña, ME; Charreau, EH; Elizalde, PV	1
Balañá, ME; Charreau, EH; Elizalde, PV; Guerra, FK; Iribarren, AM; Lanari, C; Molinolo, AA; Simian, M	1
Charreau, E; Lamb, C; Lanari, C; Luthy, IA; Molinolo, AA; Montecchia, MF; Pazos, P; Vanzulli, S	1
Anchezar Henry, JP; Gomez Rueda, N; Paniceres, G; Sardi, J; Vighi, S	1
Dgani, R; Fenig, E; Open, M; Shani, A; Vinker, S	1
Lanari, C; Molinolo, A; Montecchia, MF	1
Goto, T; Ishimaru, K; Kano, Y; Kiyono, T; Koga, T; Nishiwaki, M; Okuda, K; Sumiyama, M; Tsujitsuka, K	1
Balañá, ME; Charreau, EH; Elizalde, PV; Labriola, L; Lupu, R	1
Fukunaga, K; Miyamoto, E; Miyazaki, K; Munir, I; Okamura, H	1
Fujii, S; Kato, K; Konishi, I; Mitsushita, J; Toki, T	1
Araki, S; Koike, T; Ogawa, S; Ohwada, M; Sato, I; Shibahara, H; Suzuki, M	1
Fukunaga, M; Hataeg, M; Hiura, M; Iwasaka, T; Kaku, T; Kamura, T; Kodama, S; Kuwabara, Y; Kuzuya, K; Miyazaki, K; Nakano, H; Nishimura, T; Sakamoto, A; Sato, S; Tsuda, H; Yoshikawa, H	1
Aoki, D; Nozawa, S; Susumu, N; Suzuki, N	1
Imai, M; Jobo, T; Kawaguchi, M; Kuramoto, H; Sato, R	1
Adamian, RT	1
Besch-Williford, C; Day, JK; Hufford, MG; Lubahn, DB; MacDonald, RS; McMann, TR	1
Fujiwara, H; Kosuge, S; Ohwada, M; Sato, I; Shibahara, H; Suzuki, M; Takamizawa, S; Usui, R	1
Jikihara, H; Matsumoto, K; Nishikawa, Y; Tanizawa, O; Terada, N; Terakawa, N; Yamamoto, R	1
Angioli, R; Averette, HE; Donato, D; Nguyen, HN; Penalver, M; Perras, J; Ramos, R; Sevin, BU; Voigt, W	1
De Matties, A; De Vita, R; Di Silveiro, F; La Pera, G	1
Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K	1
Bergh, A; Damber, JE; Landström, M; Tomić, R	1
Kato, Y; Kuramoto, H; Morisawa, T	1
Charreau, EH; Dosne Pasqualini, C; Elizalde, PV; Kordon, E; Lanari, C; Molinolo, AA	1
Geyer, H; Kleine, W; Maier, T; Pfleiderer, A	1
Benedetto, MT; Bongiorno, M; De Cicco Nardone, F; Dell'Acqua, S; Iacobelli, S; Margariti, PA; Rossiello, F	1
Kawahara, T; Kobayakawa, K; Okamura, Y; Takatsuka, Y; Tsumura, I	1
Okada, H; Yamamoto, T	1
Charreau, EH; Elizalde, PV; Kordon, E; Lanari, C; Tezón, J	1
Thurzó, L	1
Titova, VA; Voznyĭ, EK	1
Charreau, E; Dosne Pasqualini, C; Elizalde, P; Kordon, E; Lanari, C; Meiss, R	1
Fujimoto, J; Fujita, H; Hosoda, S; Okada, H	1
Aoki, T; Ishikawa, M; Kakuta, T; Kimura, K; Kusama, M; Suzuki, K; Yoshimatsu, A	1
Ljungberg, B; Nilsson, TK; Tomic, R	1
Charreau, EH; Kordon, E; Lanari, C; Molinolo, A; Pasqualini, CD	1
Hando, T; Kurose, T; Motizuki, M; Ohmori, M; Sasagawa, M; Sasaki, T; Tanaka, K; Yamazaki, T; Yasuda, M	1
Katayama, T; Sasagawa, I; Satomi, S; Umeda, K	1
Fujimori, Y; Hata, T; Hirano, M; Ikeda, S; Okada, T; Tajima, H; Tomioka, Y; Yoshida, T	1
Bezwoda, WR; Derman, DP; Ruff, P; Weaving, A	1
Atkinson, EN; Freedman, RS; Scott, W; Tatman, JL	1
Berman, ML; DiSaia, PJ; Mannel, RS; Rettenmaier, MA; Stratton, JA	1
Bieglmayer, C; Kölbl, H; Schieder, K	1
Charreau, EH; Lanari, C; Molinolo, AA; Pasqualini, CD; Sanjuan, N	1
Geyer, H; Neulen, J; Pfleiderer, A; Runge, HM; Teufel, G	1
Frederiksen, PL; Kjaer, M	1
Bonte, J; Ide, P; Janssens, JP	1
Gravanis, A; Gurpide, E	1
Bensimon, H; Bunn, PA; Cohen, MH; Dunnick, NR; Eddy, JL; Ihde, DC; Javadpour, N; Makuch, RW; Minna, JD; Seifter, EJ	1
Barter, JF; Hatch, KD; Orr, JW; Shingleton, HM	1
Falkay, G; Sas, M; Thurzó, L	1
Lanari, C; Molinolo, AA; Pasqualini, CD	1
Griesinger, R; Schindler, AE	1
Atkinson, EN; Freedman, RS; Jones, LA; Kline, RC	1
Damber, JE; Landström, M; Tomić, R	1
Erkkola, R; Grenman, S; Grönroos, M; Kangas, L; Mäenpää, J; Paul, R	1
Alford, WM; Ehrlich, CE; Stehman, FB; Sutton, GP; Young, PC	1
Bellussi, G; Conti, G; Di Carlo, F; Muccioli, G; Racca, S	1
Damber, JE; Ljungberg, B; Tomić, R	2
Ikegami, H; Inoue, M; Matsumoto, K; Shimizu, I; Tanizawa, O; Terakawa, N	1
Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G	1
Audet-Lapointe, P; Ayoub, J; Beaulieu, R; Chemaly, R; Cormier, A; Déry, JP; Drouin, P; Gauthier, P; Hanley, J; Méthot, Y	1
Pronin, VN; Pukhlikov, AV	1
Lahousen, M; Pickel, H	1
Kjaer, M	1
Bell, SC; Davidson, AC; MacVicar, J; Waites, GT; Walker, RA; Wood, PL	1
Hamerlynck, JV; Mangioni, C; Maskens, AP; Rotmensz, N; van der Burg, ME; Vermorken, JB; Wils, JA	1
Barnhill, D; Dames, J; Gallup, D; Heller, P; Hoskins, W; Park, R	1
Isotalo, H; Kauppila, A; Kivinen, S; Stenbäck, F; Vihko, R	1
Cauchi, M; Fortune, D; Quinn, MA	1
Daniele, O; Fiorentino, MV; Fornasiero, A; Fosser, V; Morandi, P	1
Izutsu, T; Kagabu, T; Kurokawa, Y; Nishiya, I; Satoh, K; Yoshizumi, N	1

Reviews

7 review(s) available for medroxyprogesterone acetate and Adenocarcinoma

Article	Year
Sparing fertility in young patients with endometrial cancer. Gynecologic oncology, 2008, Volume: 111, Issue:2 Suppl Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Medroxyprogesterone Acetate; Neoplasm Staging; Progestins; Treatment Outcome; Young Adult	2008
Depo provera in perspective. Papua and New Guinea medical journal, 1981, Volume: 24, Issue:4 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Contraceptive Agents, Female; Dogs; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Pregnancy; Uterine Cervical Dysplasia; Uterine Neoplasms	1981
Development of a preclinical model for hormonal therapy of human endometrial carcinomas. Annals of medicine, 1993, Volume: 25, Issue:2 Topics: Adenocarcinoma; Animals; Endometrial Neoplasms; Estradiol; Female; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	1993
Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecologic oncology, 2000, Volume: 79, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Neoplasm, Residual; Pregnancy; Pregnancy Complications, Neoplastic	2000
[Hormonal therapy for endometrial adenocarcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic	2001
[Therapy of advanced endometrial cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Uterine Neoplasms	1990
The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma. Cancer treatment reviews, 1988, Volume: 15, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Humans; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate	1988

Trials

13 trial(s) available for medroxyprogesterone acetate and Adenocarcinoma

Article	Year
While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularity. American journal of obstetrics and gynecology, 2018, Volume: 219, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Delayed-Action Preparations; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Treatment Outcome; Waiting Lists	2018
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. The Lancet. Oncology, 2010, Volume: 11, Issue:2 Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride	2010
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial. European urology, 1983, Volume: 9, Issue:4 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Nephrectomy; Postoperative Period; Prognosis; Prospective Studies; Random Allocation; Receptors, Steroid	1983
Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma. European journal of obstetrics, gynecology, and reproductive biology, 1984, Volume: 17, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen; Uterine Neoplasms	1984
[Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate]. Bulletin du cancer, 1984, Volume: 71, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Receptors, Cell Surface; Tamoxifen; Time Factors	1984
Stage I endometrial carcinoma: the role of neoadjuvant progesterone therapy. Clinical oncology (Royal College of Radiologists (Great Britain)), 1993, Volume: 5, Issue:2 Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Survival Rate	1993
Primary hormonal treatment for early endometrial carcinoma. European journal of gynaecological oncology, 1998, Volume: 19, Issue:6 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Neoplasm Staging; Treatment Outcome	1998
[Therapy of atypical hyperplasia and adenocarcinoma of the endometrium with the combination of progestins and anticoagulants]. Voprosy onkologii, 2001, Volume: 47, Issue:3 Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Anticoagulants; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Hyperplasia; Medroxyprogesterone Acetate; Neoplasm Staging; Progesterone Congeners; Treatment Outcome	2001
[Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer]. Zentralblatt fur Gynakologie, 1990, Volume: 112, Issue:17 Topics: Adenocarcinoma; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1990
Sequential hormonal therapy and sequential hormonal and chemotherapy for advanced prostatic cancer. Oncology, 1989, Volume: 46, Issue:5 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Diethylstilbestrol; Drug Administration Schedule; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Orchiectomy; Prostatic Neoplasms; Time Factors	1989
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Drug Therapy, Combination; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Orchiectomy; Pilot Projects; Prostatic Neoplasms	1986
Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate. Cancer treatment reports, 1987, Volume: 71, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Uterine Neoplasms	1987
Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status. Gynecologic oncology, 1988, Volume: 31, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Tamoxifen; Uterine Neoplasms	1988

Other Studies

140 other study(ies) available for medroxyprogesterone acetate and Adenocarcinoma

Article	Year
Hormone-Independent Mouse Mammary Adenocarcinomas with Different Metastatic Potential Exhibit Different Metabolic Signatures. Biomolecules, 2020, 08-27, Volume: 10, Issue:9 Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Female; Glucose; Glycolysis; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Metabolome; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms, Hormone-Dependent	2020
Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report. Diagnostic pathology, 2019, Jun-07, Volume: 14, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma, Endometrioid; Cell Differentiation; Endometrial Neoplasms; Endometrium; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Mullerian Ducts; Retrospective Studies; Wolffian Ducts	2019
Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstetrics and gynecology, 2013, Volume: 122, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult	2013
Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Treatment Outcome; Uterine Hemorrhage; Young Adult	2014
Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer. Gynecologic oncology, 2016, Volume: 140, Issue:3 Topics: AC133 Antigen; Adenocarcinoma; Adult; Aged; Antigens, CD; Antineoplastic Agents, Hormonal; Apoptosis; Cell Count; Cell Line, Tumor; Endometrial Neoplasms; Female; Glycoproteins; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplastic Stem Cells; Peptides; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone	2016
Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice. Acta cirurgica brasileira, 2016, Volume: 31, Issue:4 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Carcinogenesis; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Ethylnitrosourea; Female; Letrozole; Medroxyprogesterone Acetate; Mice, Inbred BALB C; Nitriles; Progesterone; Reproducibility of Results; Time Factors; Treatment Outcome; Triazoles	2016
Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system. Journal of gynecologic oncology, 2017, Volume: 28, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Prospective Studies; Reproducibility of Results	2017
Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. International journal of oncology, 2008, Volume: 33, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Movement; Cystadenoma, Serous; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; NM23 Nucleoside Diphosphate Kinases; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Progestins; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; Time Factors	2008
Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman. Fertility and sterility, 2009, Volume: 91, Issue:3 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Adenosquamous; Cesarean Section; Chemotherapy, Adjuvant; Endometrial Neoplasms; Female; Fertility; Fiber Optic Technology; Humans; Hysteroscopy; Infant, Newborn; Live Birth; Medroxyprogesterone Acetate; Neoplasm Staging; Pregnancy	2009
Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies	2009
Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990-2006). Journal of feline medicine and surgery, 2010, Volume: 12, Issue:2 Topics: Adenocarcinoma; Animals; Cat Diseases; Cats; Immunohistochemistry; Male; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate	2010
Outcomes of conservative therapy for young women with early endometrial adenocarcinoma. Fertility and sterility, 2010, Volume: 93, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome	2010
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecologic oncology, 2013, Volume: 129, Issue:1 Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Recurrence	2013
A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecologic oncology, 2002, Volume: 87, Issue:1 Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Chickens; Disease Models, Animal; Female; Medroxyprogesterone Acetate; Ovarian Neoplasms; Ovulation; Pilot Projects	2002
Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells. Fertility and sterility, 2003, Volume: 79, Issue:1 Topics: Adenocarcinoma; Cell Division; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tumor Cells, Cultured	2003
A PROGESTATIONAL AGENT (MEDROXYPROGESTERONE ACETATE) IN TREATMENT OF PRIMARY ADENOCARCINOMA OF THE CERVIX. REPORT OF A CASE. Obstetrics and gynecology, 1964, Volume: 23 Topics: Adenocarcinoma; Female; Humans; Hysterectomy; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Pathology; Progestins; Radiography, Thoracic; Uterine Cervical Neoplasms	1964
MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE. American journal of obstetrics and gynecology, 1965, May-01, Volume: 92 Topics: Adenocarcinoma; Disease Management; Female; Geriatrics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Palliative Care; Uterine Neoplasms	1965
Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-15, Volume: 9, Issue:11 Topics: Adenocarcinoma; Cell Line, Tumor; Chondroitin Sulfate Proteoglycans; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lectins, C-Type; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Neoplasm Proteins; Receptors, Progesterone; Tenascin; Versicans	2003
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells. Fertility and sterility, 2004, Volume: 81, Issue:1 Topics: Adenocarcinoma; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Protein Isoforms; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2004
A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertility and sterility, 2004, Volume: 81, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cesarean Section; Embryo Transfer; Endometrial Neoplasms; Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progesterone; Sperm Injections, Intracytoplasmic; Ultrasonography	2004
Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor. Breast cancer research and treatment, 2004, Volume: 83, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Estradiol; Female; Gene Expression Regulation, Neoplastic; Genetic Markers; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lung Neoplasms; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	2004
Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma. Gynecologic and obstetric investigation, 2004, Volume: 58, Issue:2 Topics: Adenocarcinoma; Adult; Biopsy, Needle; Combined Modality Therapy; Dilatation and Curettage; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infertility, Female; Maternal Age; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Reproductive Techniques, Assisted	2004
Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation. Pathology international, 2004, Volume: 54, Issue:6 Topics: Adenocarcinoma; Adult; Alkaline Phosphatase; alpha-Fetoproteins; Biomarkers, Tumor; Cell Transformation, Neoplastic; Chorionic Gonadotropin; Endometrial Hyperplasia; Endometrial Neoplasms; Fatal Outcome; Female; Germinoma; GPI-Linked Proteins; Humans; Hysterectomy; Immunoenzyme Techniques; Isoenzymes; Loss of Heterozygosity; Medroxyprogesterone Acetate; Microsatellite Repeats	2004
[Effect of estrogen and progesterone on the expression of VEGF mRNA in epithelial ovarian cancer cell line]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Ovarian Neoplasms; RNA, Messenger; Vascular Endothelial Growth Factor A	2004
Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112, Issue:3 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Carcinoma; Carcinoma, Adenosquamous; Cohort Studies; Combined Modality Therapy; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Infertility, Female; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome	2005
Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin. Cancer investigation, 2006, Volume: 24, Issue:2 Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Cachexia; Enzyme-Linked Immunosorbent Assay; Female; Hypercalcemia; Indomethacin; Interleukin-1; Interleukin-6; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Paraneoplastic Syndromes	2006
Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium. Cancer letters, 2007, Apr-08, Volume: 248, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Adult; Combined Modality Therapy; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Immunohistochemistry; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Phosphorylation; Pregnancy; Progestins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Estrogen; Receptors, Progesterone; Time Factors; Treatment Outcome; Tumor Suppressor Protein p53	2007
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium. Maturitas, 2007, Aug-20, Volume: 57, Issue:4 Topics: Adenocarcinoma; Angiopoietin-1; Cell Line, Tumor; Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Receptor Modulators; Female; Humans; Medroxyprogesterone Acetate; Norpregnenes; Receptor, TIE-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Necrosis Factor-alpha	2007
Renal cell carcinoma--angioinfarction. The Journal of urology, 1984, Volume: 131, Issue:2 Topics: Adenocarcinoma; Angiography; Combined Modality Therapy; Embolization, Therapeutic; Ethanol; Follow-Up Studies; Humans; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Staging; Nephrectomy; Renal Veins; RNA; Venae Cavae	1984
Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins. Advances in experimental medicine and biology, 1981, Volume: 138 Topics: Adenocarcinoma; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Receptors, Progesterone; Uterine Neoplasms	1981
Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment. Gynecologic oncology, 1982, Volume: 14, Issue:1 Topics: Adenocarcinoma; Cell Nucleus; Cytosol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms; Vagina	1982
Regression of skeletal metastases from hypernephroma following long-term treatment with medroxyprogesterone acetate. The Journal of urology, 1982, Volume: 128, Issue:3 Topics: Adenocarcinoma; Bone Neoplasms; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1982
Clinical outcome in endometrial cancer. Obstetrics and gynecology, 1982, Volume: 60, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms	1982
Murine renal cell carcinoma: a suitable human model. Progress in clinical and biological research, 1982, Volume: 100 Topics: Adenocarcinoma; Animals; Diethylstilbestrol; Disease Models, Animal; Female; Humans; Kidney Neoplasms; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Testosterone	1982
Postoperative prophylactic use of progesterone in renal cell carcinoma. The Journal of urology, 1982, Volume: 128, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nephrectomy; Postoperative Care; Prognosis; Time Factors	1982
Use of progestogens as an adjuvant to surgery in the treatment of stage I adenocarcinoma of the uterine corpus. British journal of obstetrics and gynaecology, 1983, Volume: 90, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Castration; Female; Gestonorone Caproate; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Postoperative Period; Recurrence; Uterine Neoplasms	1983
Steroid receptors and progestinic therapy in ovarian endometrioid carcinoma. European journal of gynaecological oncology, 1982, Volume: 3, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone	1982
Complete regression of multiple pulmonary metastases in a patient with advanced renal cell carcinoma treated by occlusion of the renal artery with subsequent radical nephrectomy and progesterone. European urology, 1983, Volume: 9, Issue:4 Topics: Adenocarcinoma; Embolization, Therapeutic; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nephrectomy; Renal Artery	1983
[Clinovir treatment of adenocarcinoma of the uterus with lung metastases]. MMW, Munchener medizinische Wochenschrift, 1983, Jul-22, Volume: 125, Issue:29-30 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms	1983
Calcification of humeral metastasis of renal adenocarcinoma 8 months after medroxyprogesterone acetate therapy. The Journal of urology, 1984, Volume: 131, Issue:5 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Female; Humans; Humerus; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate	1984
Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia. American journal of obstetrics and gynecology, 1984, May-15, Volume: 149, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Cytosol; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms	1984
[Cell surface changes after high-dosage progesterone treatment in endometrial carcinoma]. Zentralblatt fur Gynakologie, 1984, Volume: 106, Issue:14 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Microscopy, Electron, Scanning; Microvilli; Middle Aged; Preoperative Care; Progesterone; Surface Properties; Uterine Neoplasms	1984
Hormone treatment and sex steroid receptors in metastatic renal cell carcinoma: report of a multicentric prospective study. Tumori, 1983, Jun-30, Volume: 69, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Nephrectomy; Prospective Studies; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Testosterone	1983
Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy. The Journal of urology, 1984, Volume: 132, Issue:2 Topics: Adenocarcinoma; Aged; Estradiol; Estrenes; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Metribolone; Middle Aged; Promegestone; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Testosterone	1984
Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstetrics and gynecology, 1980, Volume: 55, Issue:6 Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms	1980
[Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)]. Nihon Gan Chiryo Gakkai shi, 1980, Dec-20, Volume: 15, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms	1980
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. American journal of obstetrics and gynecology, 1981, Nov-01, Volume: 141, Issue:5 Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1981
High-dose medroxyprogesterone acetate (MPA) in advanced chemotherapy-resistant ovarian carcinoma: a phase II study. Cancer treatment reports, 1982, Volume: 66, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms	1982
Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats. European journal of cancer & clinical oncology, 1981, Volume: 17, Issue:11 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Doxorubicin; Drug Therapy, Combination; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Transplantation; Rats; Rats, Inbred F344	1981
Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen. Acta obstetricia et gynecologica Scandinavica, 1981, Volume: 60, Issue:6 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms	1981
Nuclear androgen receptor as marker of responsiveness to medroxyprogesterone acetate in human renal cell carcinoma. Journal of steroid biochemistry, 1981, Volume: 15 Topics: Adenocarcinoma; Cell Nucleus; Humans; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Androgen; Receptors, Steroid	1981
Progesterone treatment decreases sulfate carbohydrate antigen on endometrial carcinoma cells and inhibits the cell binding to laminin. Gynecologic oncology, 1995, Volume: 57, Issue:3 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Carbohydrate Sequence; Endometrial Neoplasms; Epitopes; Female; Humans; Immunohistochemistry; Laminin; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Metastasis; Sulfates; Tumor Cells, Cultured	1995
Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma. Breast cancer research and treatment, 1995, Volume: 35, Issue:2 Topics: Adenocarcinoma; Androgen Antagonists; Animals; Blood Physiological Phenomena; Cell Division; Dexamethasone; Dihydrotestosterone; Estradiol; Female; Flutamide; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mifepristone; Ovariectomy; Progesterone; Tumor Cells, Cultured	1995
[A report of two endometrial cancer cases in that low-dose aspirin was effective for hypercoagulopathy caused by medroxyprogesterone acetate]. Nihon Sanka Fujinka Gakkai zasshi, 1995, Volume: 47, Issue:3 Topics: Adenocarcinoma; Adult; Aspirin; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Thrombosis	1995
[Treatment of recurrent uterine endometrial cancer in adjuvant therapy with medroxyprogesterone acetate (MPA) in addition of etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Aged; Drug Administration Schedule; Endometrial Neoplasms; Etoposide; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local	1995
Effects of estrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC-3) in vitro. The Prostate, 1995, Volume: 26, Issue:1 Topics: Adenocarcinoma; Cell Membrane Permeability; Estrogens; Humans; Male; Medroxyprogesterone Acetate; Progestins; Prostatic Neoplasms; Rubidium Radioisotopes; Tumor Cells, Cultured	1995
Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas. Cancer investigation, 1995, Volume: 13, Issue:2 Topics: Adenocarcinoma; Animals; Female; Gene Expression; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Receptors, Transforming Growth Factor beta; RNA, Messenger; RNA, Neoplasm; Transforming Growth Factor alpha; Transforming Growth Factor beta; Tumor Cells, Cultured	1995
[A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14 Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Ovariectomy	1994
The parenteral toxicity of Cyclofem. Contraception, 1994, Volume: 49, Issue:4 Topics: Adenocarcinoma; Animals; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Subcutaneous; Macaca mulatta; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred ICR; Pituitary Neoplasms; Rabbits; Rats	1994
Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts. The Journal of steroid biochemistry and molecular biology, 1994, Volume: 50, Issue:1-2 Topics: Adenocarcinoma; Animals; Blotting, Northern; Cell Division; Dexamethasone; Dihydrotestosterone; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Hormones; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Tamoxifen; Transforming Growth Factor alpha; Transforming Growth Factor beta; Transplantation, Heterologous; Tumor Cells, Cultured	1994
Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Archives of gynecology and obstetrics, 1994, Volume: 255, Issue:2 Topics: Adenocarcinoma; Adult; Cesarean Section; Combined Modality Therapy; Dilatation and Curettage; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Placenta Previa; Pregnancy; Pregnancy Outcome	1994
Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology. Breast cancer research and treatment, 1993, Volume: 28, Issue:1 Topics: Adenocarcinoma; Animals; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Progesterone; Progestins; Receptors, Estrogen; Receptors, Progesterone	1993
Enhanced expression of angiotensin II receptor subtypes and angiotensin converting enzyme in medroxyprogesterone-induced mouse mammary adenocarcinomas. Biochemical and biophysical research communications, 1993, May-28, Volume: 193, Issue:1 Topics: Adenocarcinoma; Animals; Binding Sites; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Receptors, Angiotensin	1993
[Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens]. Nederlands tijdschrift voor geneeskunde, 1993, May-22, Volume: 137, Issue:21 Topics: Adenocarcinoma; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms	1993
The EnDA endometrial adenocarcinoma: an oestrogen-sensitive, metastasizing, in vivo tumour model of the rat. Journal of cancer research and clinical oncology, 1993, Volume: 119, Issue:8 Topics: Adenocarcinoma; Animals; Disease Models, Animal; Endometrial Neoplasms; Female; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Ovariectomy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen; Transplantation, Isogeneic	1993
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	1995
The nuclear channel system in endometrial adenocarcinoma exposed to medroxyprogesterone acetate. Human pathology, 1996, Volume: 27, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Cell Nucleus; Endometrial Neoplasms; Female; Glycogen; Humans; Medroxyprogesterone Acetate; Microscopy, Electron; Mitochondria; Postmenopause	1996
Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception, 1995, Volume: 52, Issue:5 Topics: Adenocarcinoma; Adult; Carcinoma, Adenosquamous; Case-Control Studies; China; Contraceptive Agents, Female; Female; Humans; International Cooperation; Kenya; Medroxyprogesterone Acetate; Mexico; Middle Aged; Risk Factors; Surveys and Questionnaires; Thailand; Uterine Cervical Neoplasms; World Health Organization	1995
Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and alpha- and beta-catenin mRNA expressions. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 57, Issue:5-6 Topics: Adenocarcinoma; alpha Catenin; beta Catenin; Cadherins; Cell Adhesion; Cell Aggregation; Cytoskeletal Proteins; Danazol; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Progesterone; Progestins; RNA, Messenger; Trans-Activators; Tumor Cells, Cultured	1996
Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proceedings of the National Academy of Sciences of the United States of America, 1996, Jun-11, Volume: 93, Issue:12 Topics: Adenocarcinoma; Animals; Base Sequence; Cell Line; Endometrial Neoplasms; Female; Haplorhini; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Molecular Sequence Data; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Progesterone; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured	1996
Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis, 1996, Volume: 17, Issue:9 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Base Sequence; Carcinogens; DNA Primers; Drug Synergism; Exons; Female; Genes, ras; Humans; Incidence; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Polymerase Chain Reaction	1996
[Hormonal therapy in the treatment of endometrial adenocarcinoma]. Ceska gynekologie, 1996, Volume: 61, Issue:4 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate	1996
Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 59, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; DNA, Neoplasm; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Medroxyprogesterone Acetate; Neoplasm Proteins; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator	1996
Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer. Human reproduction (Oxford, England), 1997, Volume: 12, Issue:5 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Embryo Transfer; Endometrial Neoplasms; Female; Fertilization in Vitro; Follow-Up Studies; Humans; Hysterectomy; Hysteroscopy; Medroxyprogesterone Acetate; Ovulation Induction; Polycystic Ovary Syndrome	1997
Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice. Carcinogenesis, 1998, Volume: 19, Issue:3 Topics: Adenocarcinoma; Animals; Carcinogens; Cocarcinogenesis; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mice, Inbred BALB C	1998
Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice. Cancer letters, 1998, Apr-10, Volume: 126, Issue:1 Topics: Adenocarcinoma; Animals; Carcinogens; Cell Division; Epidermal Growth Factor; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Salivary Glands; Tumor Cells, Cultured	1998
[Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors]. Medicina, 1997, Volume: 57 Suppl 2 Topics: Adenocarcinoma; Animals; Child; Disease Progression; ErbB Receptors; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone	1997
[Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice]. Medicina, 1997, Volume: 57 Suppl 2 Topics: Adenocarcinoma; Animals; Cell Transformation, Neoplastic; Epidermal Growth Factor; Female; Growth Substances; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Oncogenes; Receptors, Growth Factor; Transforming Growth Factor beta	1997
Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas. The Journal of steroid biochemistry and molecular biology, 1998, Volume: 67, Issue:4 Topics: Adenocarcinoma; Animals; Base Sequence; Cell Division; Female; In Situ Hybridization; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Oligonucleotides, Antisense; Receptor, IGF Type 1; Receptor, IGF Type 2; Tumor Cells, Cultured	1998
Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas. The Journal of steroid biochemistry and molecular biology, 1999, Volume: 68, Issue:1-2 Topics: Adenocarcinoma; Androgens; Animals; Binding Sites; Estradiol; Female; Flutamide; Glucocorticoids; Gonanes; Hormone Antagonists; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mifepristone; Neoplasms, Hormone-Dependent; Oligonucleotides, Antisense; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured	1999
Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate? European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 83, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Ovariectomy; Parity; Polycystic Ovary Syndrome; Radiotherapy, Adjuvant	1999
Reversal of estrogen-resistance in murine mammary adenocarcinomas. Breast cancer research and treatment, 1999, Volume: 54, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Cell Division; Drug Implants; Drug Resistance, Neoplasm; Estradiol; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Progestins; Receptors, Estrogen; Receptors, Progesterone	1999
[Successful treatment of pleuritis carcinomatosa using combination therapy of 5'-DFUR, MPA and CPA as maintenance therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:13 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pleurisy	1999
Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas. Oncogene, 1999, Nov-04, Volume: 18, Issue:46 Topics: Adenocarcinoma; Animals; Base Sequence; Carcinogens; Cell Division; DNA, Antisense; Female; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuregulin-1; Progestins; Receptor, ErbB-2; Receptor, IGF Type 1; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tumor Cells, Cultured	1999
Mitogen-activated protein kinase activation and regulation of cyclooxygenase 2 expression by platelet-activating factor and hCG in human endometrial adenocarcinoma cell line HEC-1B. Journal of reproduction and fertility, 1999, Volume: 117, Issue:1 Topics: Adenocarcinoma; Androstadienes; Antineoplastic Agents, Hormonal; Chorionic Gonadotropin; Cyclic AMP; Cyclooxygenase 2; Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Estradiol; Female; Flavonoids; Humans; Isoenzymes; Isoquinolines; Medroxyprogesterone Acetate; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mitogens; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Protein Kinase Inhibitors; Signal Transduction; Sulfonamides; Thionucleotides; Tumor Cells, Cultured; Wortmannin	1999
Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma. A case report. Gynecologic and obstetric investigation, 2001, Volume: 51, Issue:3 Topics: Adenocarcinoma; Adult; Curettage; Endometrial Neoplasms; Female; Gamete Intrafallopian Transfer; Humans; Infertility, Female; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Outcome	2001
Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer letters, 2001, Jun-10, Volume: 167, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Pregnancy; Treatment Outcome	2001
Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations. European journal of gynaecological oncology, 2001, Volume: 22, Issue:3 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Japan; Medroxyprogesterone Acetate; Prognosis; Treatment Outcome	2001
Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice. Nutrition and cancer, 2001, Volume: 39, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Caseins; Diet; Estradiol; Estrogen Receptor alpha; Female; Genistein; Insulin-Like Growth Factor I; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Ovary; Receptors, Estrogen; Skin Neoplasms; Uterus; Weight Gain	2001
Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma. American journal of reproductive immunology (New York, N.Y. : 1989), 2002, Volume: 47, Issue:3 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Uterine Neoplasms	2002
Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer. American journal of obstetrics and gynecology, 1992, Volume: 167, Issue:1 Topics: Adenocarcinoma; Animals; Cornea; Endometrial Neoplasms; Female; Fibroblast Growth Factor 1; Humans; Medroxyprogesterone Acetate; Neoplasm Transplantation; Neovascularization, Pathologic; Rabbits; Transforming Growth Factor alpha	1992
Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry. Gynecologic oncology, 1992, Volume: 46, Issue:1 Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Agents; Biological Assay; Female; Flow Cytometry; Humans; Luminescent Measurements; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms	1992
Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 41, Issue:3-8 Topics: Adenocarcinoma; Antineoplastic Agents; Cell Division; Cell Line; Endometrial Neoplasms; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Oligonucleotides, Antisense; Steroids; Tamoxifen; Transforming Growth Factor alpha; Transforming Growth Factor beta	1992
Hormonal therapy in carcinoma of the kidney. Archivos espanoles de urologia, 1991, Volume: 44, Issue:3 Topics: Adenocarcinoma; Combined Modality Therapy; DNA, Neoplasm; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Multivariate Analysis; Nephrectomy; Receptors, Cell Surface; Survival Rate	1991
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction	1991
Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology. The Journal of urology, 1991, Volume: 145, Issue:6 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Castration; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone	1991
[Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice]. Human cell, 1991, Volume: 4, Issue:2 Topics: Adenocarcinoma; Animals; Cell Division; Endometriosis; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms	1991
Estrogen inhibition of MPA-induced mouse mammary tumor transplants. International journal of cancer, 1991, Dec-02, Volume: 49, Issue:6 Topics: Adenocarcinoma; Animals; Cell Division; Delayed-Action Preparations; Estradiol; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Silicone Elastomers; Transplantation, Isogeneic	1991
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance. Gynecologic oncology, 1990, Volume: 38, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Multivariate Analysis; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Survival Analysis; Uterine Neoplasms	1990
Hormone receptors and enzymatic activities in human endometrial adenocarcinoma. Annals of the New York Academy of Sciences, 1990, Volume: 595 Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Cell Nucleus; Creatine Kinase; Cytosol; Endometrium; Female; Humans; Interferon Type I; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms	1990
[A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 1 Topics: Adenocarcinoma; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Estrogen; Remission Induction	1990
Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice. Breast cancer research and treatment, 1990, Volume: 16, Issue:1 Topics: Adenocarcinoma; Animals; Cell Division; Cell Transformation, Neoplastic; Chromatography, High Pressure Liquid; DNA Replication; Drug Interactions; Epidermal Growth Factor; Fibroblasts; Gene Expression Regulation, Neoplastic; Insulin; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Rats; Transforming Growth Factor beta	1990
[Progestins in combined treatment of endometrial cancer]. Sovetskaia meditsina, 1990, Issue:9 Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progestins; Uterine Neoplasms	1990
Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Breast cancer research and treatment, 1990, Volume: 17, Issue:1 Topics: Adenocarcinoma; Androgens; Animals; Drug Implants; Estrogens; Female; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Ovariectomy; Progesterone; Receptors, Estrogen; Receptors, Progesterone	1990
Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion & metastasis, 1989, Volume: 9, Issue:5 Topics: Adenocarcinoma; Angiogenesis Inducing Agents; Carcinoma, Squamous Cell; Cell Division; Cystadenocarcinoma; Female; Fibroblast Growth Factors; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Tumor Cells, Cultured; Tumor Stem Cell Assay	1989
[Complete remission, obtained by multidisciplinary treatment of recurrent breast cancer with carcinomatous pleuritis, and cervical lymph node and diver metastasis]. Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Pleurisy; Remission Induction	1989
Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma. Scandinavian journal of urology and nephrology, 1989, Volume: 23, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antithrombin III; Blood Proteins; Carcinoma, Renal Cell; Delayed-Action Preparations; Haptoglobins; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms	1989
Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. International journal of cancer, 1989, May-15, Volume: 43, Issue:5 Topics: Adenocarcinoma; Animals; Cell Division; Cell Line; Delayed-Action Preparations; ErbB Receptors; Female; Kinetics; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Receptors, Estrogen; Receptors, Progesterone	1989
[Diagnosis and treatment of endometrial hyperplasia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-3 Topics: ABO Blood-Group System; Adenocarcinoma; DNA Polymerase II; Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Oncogenes; Protein Biosynthesis; Receptors, Estrogen; Uterine Neoplasms	1989
[Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer]. Hinyokika kiyo. Acta urologica Japonica, 1989, Volume: 35, Issue:4 Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Prostatic Neoplasms	1989
[Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:7 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Reoperation; Uterine Neoplasms	1989
Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Thrombophlebitis; Uterine Neoplasms	1989
Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay. Gynecologic oncology, 1989, Volume: 32, Issue:1 Topics: Actuarial Analysis; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Subrenal Capsule Assay; Uterine Neoplasms	1989
[Hormone dependence of malignant ovarian tumors--an in vitro model]. Geburtshilfe und Frauenheilkunde, 1989, Volume: 49, Issue:5 Topics: Adenocarcinoma; Colony-Forming Units Assay; Cystadenocarcinoma; Female; Granulosa Cell Tumor; Humans; Krukenberg Tumor; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	1989
Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. Journal of the National Cancer Institute, 1987, Volume: 79, Issue:6 Topics: Adenocarcinoma; Animals; Delayed-Action Preparations; ErbB Receptors; Female; Hyperplasia; Immunohistochemistry; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Prolactin	1987
In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1 Topics: Adenocarcinoma; Aged; Cell Division; Cells, Cultured; Estradiol; Estrogen Antagonists; Ethanol; Female; Gestonorone Caproate; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplastic Stem Cells; Ovarian Neoplasms; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1986
High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study. Cancer treatment reports, 1986, Volume: 70, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1986
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology. European journal of gynaecological oncology, 1986, Volume: 7, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms	1986
Effects of estradiol on deoxyribonucleic acid polymerase alpha activity in the Ishikawa human endometrial adenocarcinoma cell line. The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:2 Topics: Adenocarcinoma; Cell Line; DNA Polymerase II; Enzyme Activation; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms	1986
Isolated abdominal wound recurrence of an endometrial adenocarcinoma confined to a polyp. Gynecologic oncology, 1986, Volume: 25, Issue:3 Topics: Abdominal Neoplasms; Adenocarcinoma; Combined Modality Therapy; Electrons; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Seeding; Ovariectomy; Polyps; Time Factors; Uterine Neoplasms	1986
[Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy]. Orvosi hetilap, 1986, Oct-26, Volume: 127, Issue:43 Topics: Adenocarcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1986
Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Cancer letters, 1986, Volume: 33, Issue:2 Topics: Adenocarcinoma; Animals; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Prolactin	1986
[Therapy with gestagens in hyperplastic changes of the endometrium]. Geburtshilfe und Frauenheilkunde, 1986, Volume: 46, Issue:10 Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms	1986
Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma. European urology, 1987, Volume: 13, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Doxorubicin; Epirubicin; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Rats; Testosterone	1987
Steroid receptors and response of endometrial cancer to hormones in vitro. Annales chirurgiae et gynaecologiae. Supplementum, 1987, Volume: 202 Topics: Adenocarcinoma; Adenosine Triphosphate; Drug Combinations; Drug Screening Assays, Antitumor; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Receptors, Steroid; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms	1987
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. American journal of obstetrics and gynecology, 1988, Volume: 158, Issue:4 Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Injections, Intramuscular; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1988
High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer. International journal of cancer, 1988, May-15, Volume: 41, Issue:5 Topics: Adenocarcinoma; Animals; Bromocriptine; Female; Liver; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Prolactin; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Prolactin	1988
Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma. Scandinavian journal of urology and nephrology, 1988, Volume: 22, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Dehydroepiandrosterone; Estradiol; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prolactin; Prostatic Neoplasms; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone	1988
Inhibitory effects of danazol and medroxyprogesterone acetate on [3H]thymidine incorporation in human endometrial cancer cells. Journal of steroid biochemistry, 1988, Volume: 31, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Cell Division; Danazol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured; Uterine Neoplasms	1988
[Which hormone therapy should be used in advanced breast carcinoma in males?]. Deutsche medizinische Wochenschrift (1946), 1988, Sep-02, Volume: 113, Issue:35 Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners	1988
Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma. Scandinavian journal of urology and nephrology. Supplementum, 1988, Volume: 110 Topics: Adenocarcinoma; Androgens; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Sex Hormone-Binding Globulin	1988
[Characteristics of the surgical stage in the combined treatment of poorly differentiated cancer of the corpus uteri]. Voprosy onkologii, 1988, Volume: 34, Issue:9 Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymph Node Excision; Medroxyprogesterone; Medroxyprogesterone Acetate; Mesonephroma; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Time Factors; Uterine Neoplasms	1988
[Adjuvant gestagen therapy in stage I endometrial cancer]. Zentralblatt fur Gynakologie, 1988, Volume: 110, Issue:16 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Uterine Neoplasms	1988
Immunohistological localization of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) in endometrial adenocarcinoma and effect of medroxyprogesterone acetate. British journal of obstetrics and gynaecology, 1988, Volume: 95, Issue:12 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Endometrium; Female; Glycodelin; Glycoproteins; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pregnancy Proteins; Uterine Neoplasms	1988
Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study. Gynecologic oncology, 1985, Volume: 22, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Evaluation; Drug Resistance; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms	1985
Persistence of endometrial activity after radiation therapy for cervical carcinoma. Obstetrics and gynecology, 1985, Volume: 66, Issue:6 Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Dilatation and Curettage; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Hyperplasia; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Radiotherapy; Radiotherapy Dosage; Risk; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms	1985
Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma. International journal of cancer, 1985, Feb-15, Volume: 35, Issue:2 Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Aged; Cell Nucleus; Cytosol; Danazol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Middle Aged; Pregnadienes; Receptors, Estrogen; Receptors, Progesterone; Temperature; Time Factors; Uterine Neoplasms	1985
Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate. Gynecologic oncology, 1985, Volume: 21, Issue:3 Topics: Adenocarcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Uterine Neoplasms	1985
MPA plasma levels after oral administration in gastrectomized cancer patients during chemotherapy. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1985, Volume: 4, Issue:3 Topics: Adenocarcinoma; Combined Modality Therapy; Female; Gastrectomy; Humans; Intestinal Absorption; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Metabolism; Stomach Neoplasms	1985
[Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium]. Nihon Sanka Fujinka Gakkai zasshi, 1985, Volume: 37, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; RNA, Neoplasm; Software; Uterine Neoplasms	1985